Report Detail

Pharma & Healthcare Global (United States, European Union and China) Congestive Heart Failure (CHF) Market Research Report 2019-2025

  • RnM3656096
  • |
  • 08 August, 2019
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs.
In 2019, the market size of Congestive Heart Failure (CHF) is 17900 million US$ and it will reach 27500 million US$ in 2025, growing at a CAGR of 5.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Congestive Heart Failure (CHF).

This report studies the global market size of Congestive Heart Failure (CHF), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Congestive Heart Failure (CHF) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Abiomed
Berlin Heart
Biotronik
Boston Scientific
HeartWare
Jarvik Heart
LivaNova
Medtronic
ReliantHeart
St. Jude Medical

Market Segment by Product Type
ICDs
VADs
Others

Market Segment by Application
Hospital
Clinic

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Congestive Heart Failure (CHF) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Congestive Heart Failure (CHF) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Congestive Heart Failure (CHF) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 ICDs
      • 1.3.3 VADs
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Congestive Heart Failure (CHF) Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Congestive Heart Failure (CHF) Market Size
      • 2.1.1 Global Congestive Heart Failure (CHF) Revenue 2014-2025
      • 2.1.2 Global Congestive Heart Failure (CHF) Sales 2014-2025
    • 2.2 Congestive Heart Failure (CHF) Growth Rate by Regions
      • 2.2.1 Global Congestive Heart Failure (CHF) Sales by Regions 2014-2019
      • 2.2.2 Global Congestive Heart Failure (CHF) Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Congestive Heart Failure (CHF) Sales by Manufacturers
      • 3.1.1 Congestive Heart Failure (CHF) Sales by Manufacturers 2014-2019
      • 3.1.2 Congestive Heart Failure (CHF) Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Congestive Heart Failure (CHF) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Congestive Heart Failure (CHF) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Congestive Heart Failure (CHF) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Congestive Heart Failure (CHF) Price by Manufacturers
    • 3.4 Key Manufacturers Congestive Heart Failure (CHF) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Congestive Heart Failure (CHF) Market
    • 3.6 Key Manufacturers Congestive Heart Failure (CHF) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 ICDs Sales and Revenue (2014-2019)
      • 4.1.2 VADs Sales and Revenue (2014-2019)
      • 4.1.3 Others Sales and Revenue (2014-2019)
    • 4.2 Global Congestive Heart Failure (CHF) Sales Market Share by Type
    • 4.3 Global Congestive Heart Failure (CHF) Revenue Market Share by Type
    • 4.4 Congestive Heart Failure (CHF) Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Congestive Heart Failure (CHF) Sales by Application

    6 United States

    • 6.1 United States Congestive Heart Failure (CHF) Breakdown Data by Company
    • 6.2 United States Congestive Heart Failure (CHF) Breakdown Data by Type
    • 6.3 United States Congestive Heart Failure (CHF) Breakdown Data by Application

    7 European Union

    • 7.1 European Union Congestive Heart Failure (CHF) Breakdown Data by Company
    • 7.2 European Union Congestive Heart Failure (CHF) Breakdown Data by Type
    • 7.3 European Union Congestive Heart Failure (CHF) Breakdown Data by Application

    8 China

    • 8.1 China Congestive Heart Failure (CHF) Breakdown Data by Company
    • 8.2 China Congestive Heart Failure (CHF) Breakdown Data by Type
    • 8.3 China Congestive Heart Failure (CHF) Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Company
    • 9.2 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Type
    • 9.3 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Application
    • 9.4 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Countries
      • 9.4.1 Rest of World Congestive Heart Failure (CHF) Sales by Countries
      • 9.4.2 Rest of World Congestive Heart Failure (CHF) Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Abiomed
      • 10.1.1 Abiomed Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.1.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.1.5 Abiomed Recent Development
    • 10.2 Berlin Heart
      • 10.2.1 Berlin Heart Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.2.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.2.5 Berlin Heart Recent Development
    • 10.3 Biotronik
      • 10.3.1 Biotronik Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.3.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.3.5 Biotronik Recent Development
    • 10.4 Boston Scientific
      • 10.4.1 Boston Scientific Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.4.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.4.5 Boston Scientific Recent Development
    • 10.5 HeartWare
      • 10.5.1 HeartWare Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.5.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.5.5 HeartWare Recent Development
    • 10.6 Jarvik Heart
      • 10.6.1 Jarvik Heart Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.6.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.6.5 Jarvik Heart Recent Development
    • 10.7 LivaNova
      • 10.7.1 LivaNova Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.7.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.7.5 LivaNova Recent Development
    • 10.8 Medtronic
      • 10.8.1 Medtronic Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.8.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.8.5 Medtronic Recent Development
    • 10.9 ReliantHeart
      • 10.9.1 ReliantHeart Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.9.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.9.5 ReliantHeart Recent Development
    • 10.10 St. Jude Medical
      • 10.10.1 St. Jude Medical Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
      • 10.10.4 Congestive Heart Failure (CHF) Product Introduction
      • 10.10.5 St. Jude Medical Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Congestive Heart Failure (CHF) Sales Channels
      • 11.2.2 Congestive Heart Failure (CHF) Distributors
    • 11.3 Congestive Heart Failure (CHF) Customers

    12 Market Forecast

    • 12.1 Global Congestive Heart Failure (CHF) Sales and Revenue Forecast 2019-2025
    • 12.2 Global Congestive Heart Failure (CHF) Sales Forecast by Type
    • 12.3 Global Congestive Heart Failure (CHF) Sales Forecast by Application
    • 12.4 Congestive Heart Failure (CHF) Forecast by Regions
      • 12.4.1 Global Congestive Heart Failure (CHF) Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Congestive Heart Failure (CHF) Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Congestive Heart Failure (CHF) . Industry analysis & Market Report on Congestive Heart Failure (CHF) is a syndicated market report, published as Global (United States, European Union and China) Congestive Heart Failure (CHF) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Congestive Heart Failure (CHF) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,063.52
      4,595.28
      6,127.04
      516,009.60
      774,014.40
      1,032,019.20
      274,076.80
      411,115.20
      548,153.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report